Distribution of ß-Lactamase Genes Among Multidrug-Resistant and Extended-Spectrum ß-Lactamase-Producing Diarrheagenic Escherichia coli from Under-Five Children in Ethiopia

References

• Kang E, Crouse A, Chevallier L, Pontier SM, Alzahrani A, Silué N. Enterobacteria and host resistance to infection. Mammal Geno. 2018;29(7):558–576. doi:10.1007/s00335-018-9749-4
   PubMed Web of Science ®Google Scholar
• Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013;26(4):822–880. doi:10.1128/CMR.00022-13
   PubMed Web of Science ®Google Scholar
• Lanata CF, Fischer-Walker CL, Olascoaga AC, Torres CX, Aryee MJ, Black RE. Global causes of diarrheal disease mortality in children, <5 years of age: a systematic review. PLoS One. 2013;8(9):e72788. doi:10.1371/journal.pone.0072788
   PubMed Web of Science ®Google Scholar
• Miliwebsky E, Schelotto F, Varela G, Luz D, Chinen I, Piazza RMF. Human diarrheal infections: diagnosis of diarrheagenic Escherichia coli pathotypes. In: Torres AG, editor. Escherichia Coli in the Americas. Switzerland: Springer International Publishing; 2016:343–369.
   Google Scholar
• Delgado-Valverde M, Sojo-Dorado J, Pascual A, et al. Clinical management of infections caused by multidrug-resistant Enterobacteriaceae. Ther Adv Infect Dis. 2013;1(2):49–69. doi:10.1177/2049936113476284
   PubMedGoogle Scholar
• Bush K, Bradford PA. Epidemiology of beta Lactamase-Producing Pathogens. Clin Microbiol Rev. 2020;33(2):e00047–19. doi:10.1128/CMR.00047-19
   PubMed Web of Science ®Google Scholar
• World Health Organization. Ten Threats to Global Health in 2019. World Health Organization 2019; 2019. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019. Accessed October 28, 2023.
   Google Scholar
• Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–318. doi:10.1179/2047773215Y.0000000030
   PubMed Web of Science ®Google Scholar
• World Health Organization. World Health Organization/ Antimicrobial Resistance; 2021 Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed October 28, 2023.
   Google Scholar
• Casals-Pascual C, Vergara A, Vila J. Intestinal microbiota and antibiotic resistance: perspectives and solutions. Hum Micro J. 2018;9(11):11–15. doi:10.1016/j.humic.2018.05.002
   Google Scholar
• Uddina TM, Chakrabortya AJ, Khusrob A, et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021;14(12):1750–1766. doi:10.1016/j.jiph.2021.10.020
   PubMed Web of Science ®Google Scholar
• Bush K. Past and Present Perspectives on ␤-Lactamases. Antimicrob Agents Chemother. 2018;62(10):e01076–18. doi:10.1128/AAC.01076-18
   PubMed Web of Science ®Google Scholar
• Queenan AM, Bush K. Carbapenemases: the Versatile ␤-Lactamases. Clin Microbiol Rev. 2007;20(3):440–458. doi:10.1128/CMR.00001-07
   PubMed Web of Science ®Google Scholar
• Ghafourian S, Sadeghifard N, Soheili S, Sekawi Z. Extended spectrum beta-lactamases: definition, classification and epidemiology. Curr Issues Mol Biol. 2015;17:11–22.
   PubMed Web of Science ®Google Scholar
• Shaikh S, Fatima J, Shakil S, Rizvi SM, Kamal MA. Antibiotic resistance and extended spectrum beta-lactamases: types, epidemiology and treatment. Saudi J Biol Sci. 2015;22(1):90–101. doi:10.1016/j.sjbs.2014.08.002
   PubMed Web of Science ®Google Scholar
• Liang W-J, Liu H-Y, Duan G-C, et al. Emergence and mechanism of carbapenem-resistant Escherichia coli in Henan, China, 2014. J Infect Public Health. 2018;11(3):347–351. doi:10.1016/j.jiph.2017.09.020
   PubMed Web of Science ®Google Scholar
• El-Domany RA, El-Banna T, Sonbol F, Abu-Sayedahmed SH. Co-existence of NDM-1 and OXA-48 genes in Carbapenem Resistant Klebsiella pneumoniae clinical isolates in Kafrelsheikh, Egypt. Afr Health Sci. 2021;21(2):489–496. doi:10.4314/ahs.v21i2.2
   PubMed Web of Science ®Google Scholar
• Ssekatawa K, Byarugaba DK, Nakavuma JL, et al. Carbapenem resistance profile pathogenic Escherichia coli in Uganda. Research Square. 2020.
   Google Scholar
• Han R, Shi Q, Wu S, et al. Dissemination of Carbapenemases (KPC, NDM, OXA-48, IMP, and VIM) among carbapenem-resistant Enterobacteriaceae isolated from adult and children patients in China. Front Cell Infect Microbiol. 2020;10(314). doi:10.3389/fcimb.2020.00314
   Google Scholar
• Magiorakos AP, Srinivasan A, Carey RB, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi:10.1111/j.1469-0691.2011.03570.x
   PubMed Web of Science ®Google Scholar
• Alemayehu T. Prevalence of multidrug-resistant bacteria in Ethiopia: a systematic review and meta-analysis. J Glob Anti Resist. 2021;26:133–139. doi:10.1016/j.jgar.2021.05.017
   PubMed Web of Science ®Google Scholar
• Mirzaei B, Babaei R, Bazgir ZN, Goli HR, Keshavarzi S, Amiri E. Prevalence of Enterobacteriaceae spp. and its multidrug-resistant rates in clinical isolates: a two-center cross-sectional study. Mol Biol Rep. 2021;48(1):665–675. doi:10.1007/s11033-020-06114-x
   PubMed Web of Science ®Google Scholar
• Sadeghi H, Khoei SG, Bakht M, et al. A retrospective cross-sectional survey on nosocomial bacterial infections and their antimicrobial susceptibility patterns in hospitalized patients in northwest of Iran. BMC Res Notes. 2021;14(1):88. doi:10.1186/s13104-021-05503-0
   PubMed Web of Science ®Google Scholar
• Chellapandi K, Dutta TK, Sharma I, Mandal SD, Kumar NS, Ralte L. Prevalence of multi drug resistant enteropathogenic and enteroinvasive Escherichia coli isolated from children with and without diarrhea in Northeast Indian population. Ann Clin Microbiol Antimicrob. 2017;16(1):49. doi:10.1186/s12941-017-0225-x
   PubMedGoogle Scholar
• Amare A, Eshetie S, Kasew D, Moges F, Algammal AM. High prevalence of fecal carriage of Extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae among food handlers at the University of Gondar, Northwest Ethiopia. PLoS One. 2022;17(3):e0264818. doi:10.1371/journal.pone.0264818
   PubMed Web of Science ®Google Scholar
• Tadesse S, Mulu W, Genet C, Kibret M, Belete MA, Mascellino MT. Emergence of high prevalence of extended-spectrum beta lactamase and carbapenemase-producing Enterobacteriaceae species among patients in Northwestern Ethiopia Region. Biomed Res Int. 2022;2022:1–9. doi:10.1155/2022/5727638
   Web of Science ®Google Scholar
• Legese MH, Asrat D, Aseffa A, Swedberg G, Mihret A, Swedberg G. Molecular epidemiology of extended-spectrum beta-lactamase and AmpC producing Enterobacteriaceae among sepsis patients in Ethiopia: a prospective multicenter study. Antibiotics. 2022;11(131):131. doi:10.3390/antibiotics11020131
   Google Scholar
• Seman A, Mihret A, Sebre S, et al. Prevalence and molecular characterization of extended spectrum β-lactamase and carbapenemase-producing Enterobacteriaceae isolates from bloodstream infection suspected patients in Addis Ababa, Ethiopia. Infect Drug Resist. 2022;15:1367–1382. doi:10.2147/IDR.S349566
   PubMed Web of Science ®Google Scholar
• Stechera B, Denzlera R, Maiera L, et al. Gut inflammation can boost horizontal gene transfer between pathogenic and commensal Enterobacteriaceae. PNAS. 2012;109(4):1269–1274. doi:10.1073/pnas.1113246109
   PubMed Web of Science ®Google Scholar
• Zelelie TZ, Eguale T, Yitayew B, et al. Molecular epidemiology and antimicrobial susceptibility of diarrheagenic Escherichia coli isolated from children under age five with and without diarrhea in Central Ethiopia. PLoS One. 2023;18(7):e0288517. doi:10.1371/journal.pone.0288517
   PubMed Web of Science ®Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries. 2nd ed. New York: Cambridge University Press; 2009.
   Google Scholar
• CLSI. Clinical and Laboratory Standards Institute Antimicrobial Susceptibility Testing Standards M02, M07, and M11. 29th ed. Clinical Laboratory Standards Institute; 2019.
   Google Scholar
• Mohammed Y, Gadzama GB, Zailani SB, Aboderin AO. Characterization of ExtendedSpectrum Beta-lactamase from Escherichia coli and Klebsiella Species from North Eastern Nigeria. J Clin Diagno Res. 2016;10(2):DC07–DC10. doi:10.7860/JCDR/2016/16330.7254
   PubMedGoogle Scholar
• Poirela L, Walshb TR, Cuvilliera V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119–123. doi:10.1016/j.diagmicrobio.2010.12.002
   PubMed Web of Science ®Google Scholar
• Ramachandran A, Shanthi M, Sekar U. Detection of blaCTX-M extended spectrum beta-lactamase producing salmonella enterica serotype Typhi in a Tertiary care centre. J Clin Diagno Res. 2017;11(9):DC21–DC4. doi:10.7860/JCDR/2017/30150.10637
   PubMedGoogle Scholar
• Ungo-Kore H, Bulus M, Nuhu T, et al. Genotypic detection of extended spectrum beta lactamases from selected bacterial isolates in the specialist hospital Sokoto, Nigeria. J Appl Sci Environ Manage. 2019;23(8):1573–1577.
   Google Scholar
• Ecea G, Tunc E, Otlu B, Aslan D, Ece C. Detection of blaOXA-48 and clonal relationship in carbapenem resistant K. pneumoniae isolates at a tertiary care center in Western Turkey. J Infect Public Health. 2018;11(5):640–642. doi:10.1016/j.jiph.2018.04.003
   PubMed Web of Science ®Google Scholar
• IVAC. pneumonia & Diarrhea Progress Report 2020. International Vaccine Access Center (IVAC). 2020. Available from: https://resourcecentre.savethechildren.net/pdf/ivac_pdpr_2020.pdf/. Accessed October 28, 2023.
   Google Scholar
• Wolde D, Tilahun GA, Kotiso KS, Medhin G, Eguale T. The burden of diarrheal diseases and its associated factors among under-five children in Welkite Town: a community based cross-sectional study. Int J Public Health. 2022;67:1604960. doi:10.3389/ijph.2022.1604960
   PubMed Web of Science ®Google Scholar
• Yalew M, Arefaynie M, Bitew G, Amsalu ET, Kefale B. Time to under-five mortality and its predictors in rural Ethiopia: cox-gamma shared frailty model. PLoS One. 2022;17(4):e0266595. doi:10.1371/journal.pone.0266595
   PubMed Web of Science ®Google Scholar
• Fentie AM, Degefaw Y, Asfaw G, et al. Multicentre point- prevalence survey of antibiotic use and healthcare- associated infections in Ethiopian hospitals. BMJ Open. 2022;12(2):e054541. doi:10.1136/bmjopen-2021-054541
   PubMed Web of Science ®Google Scholar
• Beyene AM, Gezachew M, Mengesha D, Yousef A, Gelaw B, Clegg S. Prevalence and drug resistance patterns of Gram-negative enteric bacterial pathogens from diarrheic patients in Ethiopia: a systematic review and meta-analysis. PLoS One. 2022;17(3):e0265271. doi:10.1371/journal.pone.0265271
   PubMed Web of Science ®Google Scholar
• Demoz GT, Kasahun GG, Hagazy K, et al. Prescribing Pattern of Antibiotics Using WHO Prescribing Indicators Among Inpatients in Ethiopia: a Need for Antibiotic Stewardship Program. Infect Drug Resist. 2020;Volume 13:2783–2794. doi:10.2147/IDR.S262104
   Web of Science ®Google Scholar
• MOH/EFDA. Ethiopian Essential Medicines List, Sixth Edition, September 2020: ministry of Health/Ethiopian Food and Drug Authority; 2020 Available from: http://efmhaca.hcmisonline.org/wp-content/uploads/2020/12/EML-sixth-edition.pdf. Accessed October 28, 2023.
   Google Scholar
• Gebeyehu E, Bantie L, Azage M, Ciccozzi M. Inappropriate use of antibiotics and its associated factors among urban and rural communities of Bahir Dar City Administration, Northwest Ethiopia. PLoS One. 2015;10(9):e0138179. doi:10.1371/journal.pone.0138179
   PubMed Web of Science ®Google Scholar
• Wallace MJ, Fishbein RS, Dantas G. Antimicrobial resistance in enteric bacteria: current state and next-generation solutions. Gut Micro. 2020;12(1):e1799654. doi:10.1080/19490976.2020.1799654
   PubMed Web of Science ®Google Scholar
• Abbasi E, Mondanizadeh M, Belkum A, Ghaznavi-Rad E. Multi-drug-resistant diarrheagenic Escherichia coli pathotypes in pediatric patients with gastroenteritis from central Iran. Infect Drug Resist. 2020;13:1387–1396. doi:10.2147/IDR.S247732
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhu X, Hou H, et al. Characteristics of diarrheagenic Escherichia coli among children under 5 years of age with acute diarrhea: a hospital based study. BMC Infect Dis. 2018;18(63). doi:10.1186/s12879-017-2936-1
   Google Scholar
• Sirous M, Hashemzadeh M, Keshtvarz M, et al. Molecular characterization and antimicrobial resistance of enteropathogenic Escherichia coli in Children from Ahvaz, Iran. Jundishapur J Microbiol. 2020;13(7):e100877. doi:10.5812/jjm.100877
   Web of Science ®Google Scholar
• Shah MS, Shah AA, Eppinger M, Ahmed S, Hameed A, Hasan F. Multidrug-resistant diarrheagenic E. coli pathotypes are associated with ready-to-eat salad and vegetables in Pakistan. J Korean Soc Appl Biol Chem. 2015;58(2):267–273. doi:10.1007/s13765-015-0019-9
   Google Scholar
• Tola MA, Abera NA, Gebeyehu YM, Tullu KD, Tullu KD. High prevalence of extended-spectrum beta lactamase-producing Escherichia coli and Klebsiella pneumoniae fecal carriage among children under five years in Addis Ababa, Ethiopia. PLoS One. 2021;16(10):e0258117. doi:10.1371/journal.pone.0258117
   PubMed Web of Science ®Google Scholar
• Tufa TB, Fuchs A, Tufa TB, et al. High rate of extended-spectrum beta lactamase-producing gram-negative infections and associated mortality in Ethiopia: a systematic review and metaanalysis. Antimicrob Resist Infect Control. 2020;9(128):1.
   PubMedGoogle Scholar
• Mandal A, Sengupta A, Kumar A, et al. Molecular epidemiology of extended-spectrum β-Lactamase–producing Escherichia coli pathotypes in diarrheal children from low socioeconomic status communities in Bihar, India: emergence of the CTX-M Type. Infect Dis. 2017;10:1–11.
   Google Scholar
• Birgy A, Cohen R, Levy C, Bidet P, Courroux C, Benani M. Community faecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae in French children. BMC Infect Dis. 2012;12(315). doi:10.1186/1471-2334-12-315
   PubMedGoogle Scholar
• Tellevik MG, Blomberg B, Kommedal Ø, Maselle SY, Langeland N, Moyo SJ. High prevalence of faecal carriage of ESBLProducing Enterobacteriaceae among children in Dar es Salaam, Tanzania. PLoS One. 2016;11(12):e0168024. doi:10.1371/journal.pone.0168024
   PubMed Web of Science ®Google Scholar
• Bastidas-Caldes C, Romero-Alvarez D, Valdez-Vélez V, et al. Extended-spectrum beta-lactamases producing Escherichia coli in South America: a systematic review with a one health perspective. Infect Drug Resist. 2022;15:5759–5779. doi:10.2147/IDR.S371845
   PubMed Web of Science ®Google Scholar
• Dela H, Egyir B, Majekodunmi AO, et al. Diarrhoeagenic E. coli occurrence and antimicrobial resistance of Extended Spectrum Beta-Lactamases isolated from diarrhoea patients attending health facilities in Accra, Ghana. PLoS One. 2022;17(5):e0268991. doi:10.1371/journal.pone.0268991
   PubMed Web of Science ®Google Scholar
• Monira S, Shabnam SA, Ali SI, et al. Multi-drug resistant pathogenic bacteria in the gut of young children in Bangladesh. Gut Pathog. 2017;9(19):1–8. doi:10.1186/s13099-017-0170-4
   PubMedGoogle Scholar
• Negeri AA, Mamo H, Gurung JM, et al. Antimicrobial resistance profiling and molecular epidemiological analysis of extended spectrum β-Lactamases produced by extraintestinal invasive Escherichia coli isolates from Ethiopia: the presence of international high-risk clones ST131 and ST410 Revealed. Front Microbiol. 2021;12(706846). doi:10.3389/fmicb.2021.706846
   PubMedGoogle Scholar
• Amin M, Sirous M, Javaherizadeh H, et al. Antibiotic resistance pattern and molecular characterization of extended-spectrum β-lactamase producing enteroaggregative Escherichia coli isolates in children from southwest Iran. Infect Drug Resist. 2022;11:1097–1104. doi:10.2147/IDR.S167271
   Google Scholar
• Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658. doi:10.2147/IDR.S173867
   PubMed Web of Science ®Google Scholar
• Samuelsen Ø, Overballe-Petersen S, Bjørnholt JV, et al. Molecular and epidemiological characterization of carbapenemase producing Enterobacteriaceae in Norway, 2007 to 2014. PLoS One. 2017;12(11):e0187832. doi:10.1371/journal.pone.0187832
   PubMed Web of Science ®Google Scholar
• Shibabaw A, Sahle Z, Metaferia Y, et al. Epidemiology and prevention of hospital-acquired carbapenem-resistant Enterobacterales infection in hospitalized patients, Northeast Ethiopia. IJID Region. 2023;7:77–83. doi:10.1016/j.ijregi.2023.02.008
   PubMedGoogle Scholar
• Beshah D, Desta AF, Woldemichael GB, et al. High burden of ESBL and carbapenemase producing gram-negative bacteria in bloodstream infection patients at a tertiary care hospital in Addis Ababa, Ethiopia. PLoS One. 2023;18(6):e0287453. doi:10.1371/journal.pone.0287453
   PubMed Web of Science ®Google Scholar
• Alemayehu E, Fiseha T, Gedefie A, et al. Prevalence of carbapenemase-producing Enterobacteriaceae from human clinical samples in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2023;23(1):277. doi:10.1186/s12879-023-08237-5
   PubMed Web of Science ®Google Scholar
• Tekele SG, Teklu DS, Legese MH, et al. Multidrug-resistant and carbapenemase-producing Enterobacteriaceae in Addis Ababa, Ethiopia. Biomed Res Int. 2021;2021:1–10. doi:10.1155/2021/9999638
   PubMed Web of Science ®Google Scholar
• AwokeI T, Teka B, Aseffa A, et al. Detection of blaKPC and blaNDM carbapenemase genes among Klebsiella pneumoniae isolates in Addis Ababa, Ethiopia: dominance of blaNDM. PLoS One. 2022;17(4):e0267657. doi:10.1371/journal.pone.0267657
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang K, Chen W, et al. Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae collected from 17 hospitals in Nanjing district of China. Antimicrob Resist Infect Control. 2020;9(15). doi:10.1186/s13756-019-0674-4
   Google Scholar
• El-Shaer S, Abdel-Rhman SH, Barwa R, Hassan R. Genetic characterization of extendedspectrum β-Lactamase- and carbapenemase producing Escherichia coli isolated from Egyptian hospitals and environments. PLoS One. 2021;16(7):e0255219.
   PubMed Web of Science ®Google Scholar
• Dembele R, Soulama I, Kaboré AD, et al. Molecular characterization of carbapenemaseProducing Escherichia coli and Salmonella in children with diarrhea in rural Burkina Faso. Research Square; 2020.
   Google Scholar
• Ndukui JG, Gikunju JK, Aboge GO, Mwanik I, Maina JN, Mbaria JM. Molecular characterization of ESBLs and QnrS producers from selected Enterobacteriaceae strains isolated from commercial poultry production systems in Kiambu County, Kenya. Microbiol Insight. 2022;15:1–8. doi:10.1177/11786361211063619
   Google Scholar
• Nwafia IN, Ohanu ME, Ebede SO, Ozumba UC. Molecular detection and antibiotic resistance pattern of extended-spectrum beta-lactamase producing Escherichia coli in a Tertiary Hospital in Enugu, Nigeria. Ann Clin Microbiol Antimicrob. 2019;18(41). doi:10.1186/s12941-019-0342-9
   PubMedGoogle Scholar
• Ahmadian L, Haghshenas MR, Mirzaei B, Bazgir ZN, Goli HR. Distribution and molecular characterization of resistance gene cassettes containing class 1 integrons in Multi-Drug Resistant (MDR) clinical isolates of pseudomonas aeruginosa. Infect Drug Resist. 2020;13:2773–2781. doi:10.2147/IDR.S263759
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi:10.1016/S1473-3099(09)70054-4
   PubMed Web of Science ®Google Scholar